Want to join the conversation?
RBC Capital Markets analyst Michael Yee questions $GILD on the payor mix shift, especially on Medicaid and what percent of sales Medicaid is. COO Kevin Young says that all the public payors lumped together for the quarter were about 45%, driven by VA. The company says little has changed in the scale and size of the Medicaid business.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.